Lymphomas differ in their dependence on Epstein-Barr virus
about
Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr VirusPD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse ModelMolecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort StudyEpstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.Epstein-Barr virus: the path from association to causality for a ubiquitous human pathogen.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells.Epstein-Barr virus maintains lymphomas via its miRNAs.How human tumor viruses make use of autophagy.Oncogenic mechanisms in Burkitt lymphomaPosttransplant lymphoproliferative disease following liver transplantation.Inhibition of germinal centre apoptotic programmes by epstein-barr virus.Burkitt lymphoma: the role of Epstein-Barr virus revisited.Replication of Epstein-Barr viral DNA.Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samplesmiR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management.Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.EBV and Apoptosis: The Viral Master Regulator of Cell Fate?Comprehensive review of post-organ transplant hematologic cancers.The Role of Transforming Growth Factor β in Cell-to-Cell Contact-Mediated Epstein-Barr Virus Transmission.Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib.Infection of Epstein⁻Barr Virus in Type III Latency Modulates Biogenesis of Exosomes and the Expression Profile of Exosomal miRNAs in the Burkitt Lymphoma Mutu Cell LinesEpstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
P2860
Q26852071-965D7FAA-6945-46B7-A642-E1571DF37229Q27313748-87DD7015-C846-4FD2-BDAD-F64EBA7AB99FQ30610963-38A66FD2-15D5-4A41-865B-41ECAF2C0428Q33874038-295A2F77-0EE4-4621-9C4B-2B7A0974F6E3Q34283174-DD683F87-3E03-4287-9A30-AD36F4713448Q35236719-555A47ED-E15A-44E3-8BD1-4C5E965C8915Q35242466-B16AD447-3F91-4DB2-A5F4-8FF84BA167D7Q35808018-6D26FA12-E250-4CE2-9824-053380555734Q35858022-FBAAF23C-B18E-4A37-B8DB-97D4BB98501AQ36052985-AE7FE177-DC3D-4136-8C80-7D62A9B54AD6Q36948327-D5756316-BBCA-41C1-BFF1-CF8037AFE0E5Q37512260-2B77FDA5-6A51-4A92-B123-44174C182241Q37522401-D551F3FB-B59B-44AE-B3E7-4C1AA7B0A432Q37862042-E4A9F615-549D-4286-8A41-46525D59D328Q37959963-31F2BF42-A991-4B5C-BE76-5C8293E66372Q38000577-AF0BC704-42CE-4EF9-B7F7-AF79A4FD477CQ38071281-A30584D4-632D-4698-B95C-EBD444A33418Q38188591-9F254CEA-4EFB-4208-80A3-ADA6323D44CCQ38407022-7C6F934C-7D11-4535-BC57-8A826A7244D4Q38780780-2B983515-A18E-4657-A75A-A4EADEA842DAQ38833567-4FD3DE9A-5406-4A74-888B-A7FAA43CE5A0Q38962956-6A90939F-D693-44A8-95E6-0893C207B697Q40127660-A61B9D72-BB75-4EBC-BAC4-19FCCC7E15E2Q40375799-9B7D97C0-AAD8-43A4-B3BF-BEBA1121880EQ40696036-C8EDE0AE-6B84-4780-9A9D-AF29534DF199Q40943150-B2BE4503-5916-4FB2-9722-986BC003CAAEQ41826795-72F17792-6BA9-4209-9343-CF56E649D218Q41928227-BDFFDC42-79C2-4229-80CA-F1D0846961A0Q42272334-10BB95BF-09D1-4BAC-9900-F7831BF69FBBQ45324502-40D7E0DD-69C9-4154-9DE6-5B78C19C36EEQ47117102-068D5BF0-3E67-46F6-BDDA-AFADF31DE5A2Q47572480-E77CE093-2D80-4EC7-8182-4EAAE9896BBAQ54942659-CFCDDE4A-0A29-4D15-9B3A-F906641FB6A4Q55221402-F1D39D78-EFED-4A34-9641-EFCB364E9C11Q57267992-0EAAA7FF-14E2-43FA-94A8-6F8B44C734F7Q58803477-A63D61DF-4179-4B47-80CF-A460C0CE1A5F
P2860
Lymphomas differ in their dependence on Epstein-Barr virus
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lymphomas differ in their dependence on Epstein-Barr virus
@ast
Lymphomas differ in their dependence on Epstein-Barr virus
@en
Lymphomas differ in their dependence on Epstein-Barr virus
@nl
type
label
Lymphomas differ in their dependence on Epstein-Barr virus
@ast
Lymphomas differ in their dependence on Epstein-Barr virus
@en
Lymphomas differ in their dependence on Epstein-Barr virus
@nl
prefLabel
Lymphomas differ in their dependence on Epstein-Barr virus
@ast
Lymphomas differ in their dependence on Epstein-Barr virus
@en
Lymphomas differ in their dependence on Epstein-Barr virus
@nl
P2860
P4510
P1433
P1476
Lymphomas differ in their dependence on Epstein-Barr virus
@en
P2093
Bill Sugden
David T Vereide
P2860
P304
P356
10.1182/BLOOD-2010-05-285791
P407
P577
2010-11-18T00:00:00Z